Delivery Order SPE2DB24D1021-SPE2DB24FETJP
Award Date
8/13/24
Potential Completion Date
9/4/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $9,367.94 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office Division for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 mg. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,845.85 firm fixed-price contract is for the delivery of 120 tablets of the prescription drug NUBEQA 300 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the drug NUBEQA 300 MG, and has a completion date of November 12, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,036.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,042,325 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. This delivery order falls under a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA to supply a comprehensive range of medications and medical supplies to support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The potential value of this delivery order is $14,073.60, with a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and this contract does not have a set-aside designation. The...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a period of performance through March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,845.85 firm fixed-price delivery order is for the supply of 120 tablets of the medication NUBEQA 300 MG. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Department of Defense (DoD) has awarded a $3,518.40 delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 120 tablets of the prescription medication NUBEQA 300 MG. This order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $9,367.94, is for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The contract has a firm fixed-price pricing type and an ultimate completion date of October 3, 2024. The award was made on September 12, 2024, and there is no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,845.85, is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of December 23, 2024. It was awarded on December 2, 2024, and there is no set-aside designation, indicating open competition....